Date & Location
Wednesday, February 10, 2021, 7:00 PM - 8:15 PM EST, Online, Philadelphia, PA
The Updates in Melanoma CME will feature faculty from Penn Medicine’s Melanoma Disease team who will discuss the latest updates in melanoma treatment, focusing on the following:
- A case study presentation
- Complete lymph node dissection versus observation
- Indications for sentinel lymph node biopsy
- Stage II clinical trials
- Treatment of metastatic melanoma
- Impacts of COVID-19 on delivery of care
- COVID-19 vaccination guidelines for cancer patients
Participate in this LIVE webcast to gain up-to-date information with immediate clinical application.
Who should attend
This activity is directed toward medical and surgical oncologists, dermatologists, dermatopathologists, and other health care professionals involved in the treatment of patients with melanoma.
Specialties - FAMILY MEDICINE, INTERNAL MEDICINE - Medical Oncology
After completing this activity, participants should be able to:
- Identify the role of surgery for patients with melanoma
- List current treatment options for patients with high risk melanoma
- Describe new approaches to treatment for patients with metastatic melanoma
- Identify standards of care of cancer patients during the COVID-19 era
In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Penn medicine designates this live activity for a maximum of 1.25 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AMA PRA Category 1 Credits™ (1.25 hours), Non-Physician Attendance / Participation (1.25 hours)